 |
|
| Venture Capital Bio Life Sciences (page 1 of 20) |
|
-5AM-
Offices: Menlo Park, California & Waltham, Massachusetts
5AM Ventures is a $65 million seed and early-stage fund that is focused
on creating and building the next generation of leading biotechnology companies.
5AM works with entrepreneurs and scientists to help shape the strategic
mission of new start-ups (or spin-outs) and provides business, financial,
deal structuring, recruiting and other assistance in the company-building
process. 5AM provides the initial stages of capital, either alone or in
a VC syndicate, bringing companies to critical value-creating milestones
which enable subsequent financings with established VC firms.
Offices: Edina, Minnesota
7 Health Ventures is a professional venture capital fund dedicated to investing
in Israeli and Israeli-related companies, developing healthcare technologies
and products. Their commitment to their entrepreneurs is for a long-term
partnership because they understand that building a successful company takes
time. They accompany their entrepreneurs with integrity, resourcefulness
and dedication. Their goal is to bring their ideas to life by helping them
turn their vision into breakthrough technologies and robust products.
Offices: Auburndale, Massachusetts
At 20/20, they have assembled a group of experts with a diverse range of
backgrounds who have developed a vision for healthcare in the year 2020.
This vision guides their strategy for developing and commercializing technologies
that they feel will accelerate the implementation of successful 'Personalized
Medicine' approaches. Their team approach relies on an efficient and strategic
use of time and resources, to bring their portfolio companies' products
to market.-Aberdare-
Offices: San Francisco, California
The Aberdare Ventures team are experienced venture investors and operators
of healthcare technology companies. Their investment focus is driven by
their years of experience growing biopharmaceutical product companies and
therapeutic medical device companies. They have plenty of experience leading
early-stage investments, but they are comfortable co-investing as well.
Aberdare is willing to participate in financings as small as $1 million,
but also has the capacity to invest $4-7 million in a company over time.
Offices: Palo Alto, California; Boston, Massachusetts & London, England
Abingworth is a long-established venture capital firm specializing in unquoted
and life science biomedical companies. Abingworth is active on both sides
of the Atlantic and, in the past fifteen years, has backed more than 80
developing life science/medical businesses. The majority of these have gone
on to public offerings or have merged or been acquired by leading companies
in the industry. Abingworth has funds under management of over $700 million.
Offices: San Francisco, California
Acacia Venture Partners specializes in solely in identifying and building
leading service businesses in the healthcare industry. They firmly believe
that industry focus is critical to creating long term value in healthcare.
Acacia's team of venture capital professionals has been investing in healthcare
since the early 1980's. They have developed a deep industry understanding
and a robust network of contact in the healthcare industry.
Offices: Atlanta, Georgia; Newport Beach, California & Rochester, Minnesota
Accuitive is a venture capital firm in business to finance and help develop
early and expansion stage medical device and technology companies. AMV has
established relationships with some of the industry's leading institutions
to offer emerging companies and investors the opportunity to work with AMV
in building unique new businesses and long-term shareholder value. In addition,
AMV's connections to some of the industry’s leading practitioners and thought
leaders across multiple specialties enable them to add substantial value
both as an investor and Board member.
Offices: The Netherlands
Aescap Venture is a new Venture Capital Company targeted at European biomedical
companies. Their added value is based on best of breed investment managers.
All with a proven track record and the ability to coach and stimulate entrepreneurs
in the creation and growth of their companies. Their aim is to accelerate
the creation of value in the companies they invest in.
Offices: Minneapolis, Minnesota
Affinity Capital Management invests in private, US-based health care companies.
Within health care, they focus on the medical device, biotech, health care
service and health care information technology sectors. They prefer
companies with proprietary technology that have the potential to achieve
and sustain leadership positions in large growing markets.
Offices: New York, New York
Aisling Capital Believes the next decade will be marked by a revolution
in healthcare driven by new therapeutics generated by biotechnology. The
completion of human genome has given scientists new insights into the cause
of human disease. These insights, combined with the past 20 years of developments
in the biotechnology industry, are leading to rapid expansion of novel approaches
toward the diagnosis, prevention, and treatment of life-threatening illnesses.
Print
(page 2)
Resources
to
top